share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Bhatia Sangeeta N.

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Bhatia Sangeeta N.

福泰製藥 | 4:持股變動聲明-董事 Bhatia Sangeeta N.
美股sec公告 ·  08/12 16:12
Moomoo AI 已提取核心訊息
On August 8, 2024, Sangeeta N. Bhatia, associated with Vertex Pharmaceuticals Inc. (VRTX), completed a transaction involving the sale of 1,292 shares of common stock at a price of $466.29 per share. The transaction resulted in a total market value of $602,446.68. Prior to this sale, Bhatia exercised options to acquire the same number of shares at $152.74 each. Following the transactions, Bhatia's direct holdings in Vertex Pharmaceuticals common stock amounted to 4,435 shares. The sale was conducted as an open market or private sale, while the acquisition was due to the exercise or conversion of derivative security.
On August 8, 2024, Sangeeta N. Bhatia, associated with Vertex Pharmaceuticals Inc. (VRTX), completed a transaction involving the sale of 1,292 shares of common stock at a price of $466.29 per share. The transaction resulted in a total market value of $602,446.68. Prior to this sale, Bhatia exercised options to acquire the same number of shares at $152.74 each. Following the transactions, Bhatia's direct holdings in Vertex Pharmaceuticals common stock amounted to 4,435 shares. The sale was conducted as an open market or private sale, while the acquisition was due to the exercise or conversion of derivative security.
2024年8月8日,與福泰製藥(VRTX)有關的Sangeeta N. Bhatia以466.29美元/股的價格出售了1292股普通股的交易。該交易導致總市值爲602,446.68美元。在此次出售之前,Bhatia行使了以每股152.74美元的價格獲得相同數量股份的期權。在完成這些交易後,Bhatia在福泰製藥普通股中的直接持股總數爲4435股。出售是通過公開市場或私人出售進行的,而收購則是由於行使或轉換衍生證券而進行的。
2024年8月8日,與福泰製藥(VRTX)有關的Sangeeta N. Bhatia以466.29美元/股的價格出售了1292股普通股的交易。該交易導致總市值爲602,446.68美元。在此次出售之前,Bhatia行使了以每股152.74美元的價格獲得相同數量股份的期權。在完成這些交易後,Bhatia在福泰製藥普通股中的直接持股總數爲4435股。出售是通過公開市場或私人出售進行的,而收購則是由於行使或轉換衍生證券而進行的。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息